Emerging Strategies in the Personalized Treatment of Breast Cancer – Module 3
Molecular Subtypes and Markers in Breast Cancer
This webcast is jointly provided by A. Webb Roberts Center for CME of Baylor Health Care System and CancerNet.
For more information visit: www.cancernetus.com
This activity is supported in part by an independent education grants from Eisai, Inc, Genentech, Novartis Pharmaceuticals Corporation, and Astrazeneca.
Scroll to the Bottom of this Information to Begin This Course
Release date: September 5, 2014
Valid through: September 5, 2015
Estimated Time to Complete Activity: 1.5 hours (83 minutes)
This webcast is directed primarily to hematologists/oncologists, radiation oncologists, surgical oncologists, pathologists, researchers, pharmacists, registered nurses, physician assistants, nurse practitioners and fellows in training interested in new developments for treatment of breast cancer. No specific skill or knowledge other than a basic training in hematology/oncology is required for successful participation in this activity.
Statement of Need/Program Overview
This webcast is intended to improve care of patients with breast cancer by accelerating adoption of new guidelines and evidence-based practice change. In addition to chemotherapy and targeted therapy of breast cancer, this symposium will focus on individualized treatment options. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This enduring online activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.
Upon completion of this activity, participants should be better able to:
- Indicate the utility of molecular profiling in breast cancer patients
- Identify the use of prognostication tools such as EndoPredict Score and Oncotype DX RS for breast cancer
- Physicians — maximum of 1.5 AMA PRA Category 1 Credits™
All other healthcare professionals completing this course will be issued a statement of participation.
Merrick Ross, MD, Charles M. McBride Distinguished Professor, Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
Fraser W. Symmans, MD, Professor, Director, Research Operations, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of A. Webb Roberts Center for CME of Baylor Health Care System and CancerNet. The A. Webb Roberts Center for CME of Baylor Health Care System is accredited by the ACCME to provide continuing medical education for physicians.
The A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the webcast.
Disclosures of Conflicts of Interest
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME webcast:
- Consultant: GSK, Merck
- Advisory Board: Amgen
- Founder/Inventor: Nuvera Biosciences, Inc
- Stock holder: ISIS Pharmaceuticals, Amgen
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME webcast:
- Consultant: Genentech/Roche, Shinogi, AstraZeneca, Cepheid, Celgene
- Expert Testimony: Novartis
- No relevant financial relationships.
All other individuals in a position to control content have no relevant financial relationships to disclose.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this webcast. During the period September 5, 2014 through September 5, 2015, participants must read all of the material and study the educational webcast.
Hardware and Software Requirements
This site is best viewed with an HTML5 compatible browser, this list includes the versions of Mircrosoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.
Instructions For Course Participation
This webcast includes text, graphics, and may include multimedia features. There are no fees for participating in or receiving credit for this webcast.
Click on all of the "medical education webcast" links and review the content presented. You must view all of the content to proceed to the post-test.
Read, complete, and submit answers to the post-test questions and evaluation questions online. You must answer all missed questions until you get them correct.
Participants must receive a test score of 75% in order to proceed to the course evaluation, and they must respond to all evaluation questions to receive a letter of credit.
If needed, you may save your answers and return to complete your course at a later date. You can find your saved course by selecting "My Courses" or through the main course catalog.
Letter Of Credit & Transcripts
After submitting the webcast evaluation you will have immediate access to view and download your letter of credit as a PDF. You may print the letter of credit, but you may not alter the letter of credit. You can access all your credit letters from the "My Courses" page.
A. Webb Roberts Center for CME of Baylor Health Care System observes privacy and confidentiality of CME information and personal information of CME participants. Third parties receive only aggregated data about CME activities that are relevant to their interests and/or the activities they support. To contact CME Provider, call 214-820-2317.